ILEPATRIL Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

A dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, for the potential treatment of hypertension and diabetic nephropathy. Ilepatril is currently in phase IIb/III clinical trials for hypertension and phase II trials for diabetic nephropathy.

ILEPATRIL Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ILEPATRIL Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49374	58
TargetMol Chemicals Inc.	+8613564774135	zijue.cai@tsbiochem.com	United States	19885	58
LGM Pharma	1-(800)-881-8210	inquiries@lgmpharma.com	United States	2123	70
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60
Energy Chemical	021-58432009 400-005-6266	marketing@energy-chemical.com	China	44918	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24644	58

---

• ILEPATRIL
• (4S,7S,12bR)-7-[[(2S)-2-(Acetylthio)-3-methyl-1-oxobutyl]amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxopyrido[2,1-a][2]benzazepine-4-carboxylic acid
• lepatril
• Pyrido[2,1-a][2]benzazepine-4-carboxylic acid, 7-[[(2S)-2-(acetylthio)-3-methyl-1-oxobutyl]amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo-, (4S,7S,12bR)-
• 473289-62-2
• Amines
• Chiral Reagents
• Heterocycles
• Inhibitors
• Intermediates & Fine Chemicals
• Pharmaceuticals
• Sulfur & Selenium Compounds